Selective modulation of inducible nitric oxide synthase isozyme in myocardial infarction

Circulation

Volumn 96, Issue 5, 1997, Pages 1616-1623

  Wildhirt, Stephen M ^a   Suzuki, Hiroshi ^b   Horstman, Damian ^b   Weismüller, Susanne ^a   Dudek, Ryszard R ^b   Akiyama, Kazuhide ^b   Reichart, Bruno ^a  

^a UNIVERSITY OF MUNICH   (Germany)

^b HUNTINGTON MEDICAL RESEARCH INSTITUTES   (United States)

Author keywords

Hemodynamics; Ischemia; Myocardial infarction; Regional blood flow

Indexed keywords

NITRIC OXIDE SYNTHASE;

ACUTE HEART INFARCTION; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME INDUCTION; ENZYME POLYMORPHISM; HEART HEMODYNAMICS; HEART LEFT VENTRICLE ENDDIASTOLIC PRESSURE; HEART LEFT VENTRICLE FAILURE; HEART MUSCLE BLOOD FLOW; MALE; NONHUMAN; PRIORITY JOURNAL; RABBIT;

EID: 0030805367     PISSN: 00097322     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.CIR.96.5.1616     Document Type: Article

References (38)

1. 2+-independent nitric oxide synthase in the myocardium. Br J Pharmacol. 1992;105:575-580.
2. Worrall NK, Lazenby WD, Misko TP, Lin TS, Rodi CP, Manning PT, Tilton RG, Williamson JR, Ferguson TB. Modulation of in vivo alloreactivity by inhibition of inducible nitric oxide synthase. J Exp Med. 1995;181:63-70.
3. Russel ME, Wallace AF, Wyner LR, Newell JB, Karnovsky MJ. Upregulation and modulation of inducible nitric oxide synthase in rat cardiac allografts with chronic rejection and transplant arteriosclerosis. Circulation. 1995;92:457-464.
4. Yang X, Chowdhury N, Cai B, Marboe C, Sciacca RR, Michler RE, Cannon PJ. Induction of myocardial nitric oxide synthase by cardiac allograft rejection. J Clin Invest. 1994;94:714-721.
5. Wildhirt SM, Dudek RR, Suzuki H, Pinto V, Narayan SK, Bing RJ. Immunohistochemistry in the identification of nitric oxide synthase in myocardial infarction. Cardiovasc Res. 1995;29:526-531.
6. Wildhirt SM, Dudek RR, Suzuki H, Narayan KS, Winder S, Choe J, Bing RJ. Expression of nitric oxide synthase isoforms after myocardial infarction in humans. Endothelium. 1995;3:209-224.
7. Brady AJB, Poole-Wilson PA, Harding SE, Warren JB. Nitric oxide production within cardiac myocytes reduces their contractility in endotoxemia. Am J Physiol. 1992;263:H1963-H1966.
8. Balligand JL, Ungureanu D, Kelly RA, Kobzik L, Pimentai D, Michel T, Smith TW. Abnormal contractile function due to induction of nitric oxide synthesis in rat cardiac myocytes follows exposure to activated macrophage-conditioned medium. J Clin Invest. 1993;91:2314-2319.
9. Hare JM, Keany JF, Balligand JL, Loscalzo J, Smith TW. Role of nitric oxide in parasympathetic modulation of β-adrenergic myocardial contractility in normal dogs. J Clin Invest. 1995;95:360-366.
10. Brady AJB, Warren JB, Poole-Wilson PA, Williams TJ, Harding SE. Nitric oxide attenuates cardiac myocyte contraction. Am J Physiol. 1993;265:H176-H182.
11. Wright CE, Rees DR, Moncada S. Protective and pathological roles of nitric oxide in endotoxin shock. Cardiovasc Res. 1992;26:48-57.
12. Petros A, Lamb G, Leone A, Moncada S, Benett D, Vallance P. Effects of a nitric oxide synthase inhibitor in humans with septic shock. Cardiovasc Res. 1994;28:34-39.
13. Du ZY, Dusting GJ, Woodman OL. Haemodynamic responses to N-nitro-L-arginine in conscious rabbits. Clin Exp Pharm Physiol. 1991;18:371-374.
14. Joly GA, Ayres M, Chelly F, Kilbourn RG. Effects of N-methyl-L-arginine, N-nitro-L-arginine and aminoguanidine on constitutive and inducible nitric oxide synthase in rat aorta. Biochem Biophys Res Commun. 1994;199:147-154.
15. Garvey EP, Opliner JA, Tanoury GJ, Sherman PA, Fowler M, Marshall S, Harmon MF, Faith JE, Furfine ES. Potent and selective inhibition of human nitric oxide synthases. J Biol Chem. 1994;269: 26669-26676.
16. Tracey WR, Nakane M, Basha F, Carter G. In vivo pharmacological evaluation of two novel type II (inducible) nitric oxide synthase inhibitors. Can J Physiol Pharmacol. 1995;73:665-669.
17. Southan GJ, Szabo C, Thiemermann C. Isothioureas: potent inhibitors of nitric oxide synthase with variable isoform selectivity. Br J Pharmacol. 1995;114:510-516.
18. Szabo C, Southan GJ, Thiemermann C. Beneficial effects and improved survival in rodent models of septic shock with S-methylisothiourea sulfate, a potent and selective inhibitor of inducible nitric oxide synthase. Proc Natl Acad Sci U S A. 1994;91: 12472-12476.
19. Karam R, Healy BP, Wickler P. Coronary reserve is depressed in postmyocardial infarction reactive hypertrophy. Circulation. 1990; 81:238-246.
20. Drexler H, Hablawetz E, Lu W, Riede U, Christes A. Effects of nitric oxide formation on regional blood flow in experimental myocardial infarction. Circulation. 1992;86:255-262.
21. Mahaffey KW, Raya TE, Pennock G, Morkin E, Goldman S. Left ventricular performance and remodeling in rabbits after myocardial infarction. Circulation. 1995;91:794-802.
22. Dudek RR, Wildhirt SM, Conforto A, Pinto V, Suzuki H, Winder S, Bing RJ. Inducible nitric oxide synthase activity in myocardium after myocardial infarction in rabbit. Biochem Biophys Res Commun. 1994;205:1671-1680.
23. Li Y, Whittaker P, Kloner RA. The transient nature of the effect of ischemic preconditioning on myocardial infarct size and ventricular arrhythmia. Am Heart J. 1992;123:346-353.
24. Bredt DS, Snyder SH. Isolation of nitric oxide synthetase, a calmodulin requiring enzyme. Proc Natl Acad Sci U S A. 1989;87:682-685.
25. Steiner AL, Pagliari AS, Chase LR, Kipnis DM. Radioimmunoassay for cyclic nucleotides, II: adenosine 3′,5′-monophosphate and guanosine 3′,5′-monophosphate in mammalian tissue and body fluids. J Biol Chem. 1972;247:1114-1120.
26. Glenny RW, Bernard S, Brinkley M. Validation of fluorescent labeled microspheres for measurement of regional organ perfusion. J Appl Physiol. 1993;74:2585-2597.
27. Gardiner SM, Compton AM, Kemp PA, Bennett T. Hemodynamic effects of N-monomethyl-L-arginine and N-nitro-L-arginine-methyl-ester in conscious unrestrained rats. J Cardiovasc Pharmacol. 1991;17:173-181.
28. Ward JE, Angus JA. Acute and chronic inhibition of nitric oxide synthase in conscious rabbits: role of nitric oxide in the control of vascular tone. J Cardiovasc Pharmacol. 1993;21:804-814.
29. Cobb JP, Natanson C, Quezabo ZMN, Huffman WD, Koev CA, Banks S, Correa R, Levi R, Elin RJ, Hosseini JM, Danner RL. Differential hemodynamic effects of L-NMMA in endotoxemic and normal dogs. Am J Physiol. 1995;268:H-1634-H-1642.
30. Armani M, O'Shea J, Allen NJ. Role of basal release of nitric oxide on coronary flow and mechanical performance of the isolated rat heart. J Physiol (Lond). 1992;456:681-687.
31. Schulz R, Panas DL, Catena R, Moncada S, Olley PM, Lopaschuk GD. The role of nitric oxide in cardiac depression induced by interleukin-1β and tumour necrosis factor alpha. Br J Pharmacol. 1995;114:27-34.
32. Balligand JL, Kelly RA, Marsden PA, Smith TW, Michel T. Control of cardiac muscle cell function by an endogenous nitric oxide signaling system. Proc Natl Acad Sci U S A. 1993;90:347-351.
33. Imai S. Cyclic GMP as a second messenger in the cardiovascular system. Jpn Heart J. 1995;36:127-177.
34. Balligand JL, Ungureanu-Longrois D, Simmons WW, Pimentai D, Malinski TA, Kapturczak M, Taha Z, Lowenstein CJ, Davidiff AJ, Kelly RA, Smith TW, Michel T. Cytokine-inducible nitric oxide synthase (iNOS) expression in cardiac myocytes. J Biol Chem. 1994; 269:27580-27588.
35. Zanzinger J, Czachurski J, Seller H. Inhibition of sympathetic vasoconstriction is the major principle of vasodilation by nitric oxide in vivo. Circ Res. 1994;75:1073-1077.
36. Hibbs JB Jr, Taintor RR, Vavrin Z, Granger DL, Drapier JC, Amber IJ, Lancaster JR. Synthesis of nitric oxide from a terminal guanidino nitrogen atom of L-arginine: a molecular mechanism regulating cellular proliferation that targets intracellular iron. In: Moncada S, Higgs EA, eds. Nitric Oxide From L-Arginine: A Bioregulatory System. Amsterdam, Netherlands: Excerpta Medica; 1990:189-224.
37. Beckman JS, Beckman TW, Chen J, Marshall PA, Freeman BA. Apparent hydroxyl radical production by peroxynitrite: implications for endothelial injury from nitric oxide and superoxide. Proc Natl Acad Sci U S A. 1990;87:1620-1624.
38. Ma TT, Ischiropoulos H, Brass CA. Endotoxin-stimulated nitric oxide production increases injury and reduces rat liver chemiluminescence during reperfusion. Gastroenterology. 1995;108:463-469.